Surrozen (SRZN) closed at $25.14 on October 20, 2026, up 5.5% from the previous close, on volume of 316,088 shares (30-day average 859,038).
Data as of October 20, 2026.
No headlines found.
Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million
Globe Newswire (Tue, 20-Oct 4:59 PM ET)
Globe Newswire (Fri, 2-Oct 8:00 AM ET)
Globe Newswire (Tue, 8-Sep 8:30 AM ET)
Surrozen to Present at Upcoming Healthcare Investor Conferences
Globe Newswire (Wed, 2-Sep 4:05 PM ET)
Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update
Globe Newswire (Thu, 6-Aug 4:05 PM ET)
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Surrozen trades on the NASDAQ stock market under the symbol SRZN.
As of October 20, 2026, SRZN stock price climbed to $25.14 with 316,088 million shares trading.
SRZN has a beta of 2.05, meaning it tends to be more sensitive to market movements. SRZN has a correlation of 0.07 to the broad based SPY ETF.
SRZN has a market cap of $295.48 million. This is considered a Small Cap stock.
Last quarter Surrozen reported $5 million in Revenue and -$.41 earnings per share. This beat revenue expectation by $4 million and exceeded earnings estimates by $.87.
In the last 3 years, SRZN traded as high as $37.83 and as low as $4.50.
The top ETF exchange traded funds that SRZN belongs to (by Net Assets): VTI, IWM, JSMD, VXF, IWO.
SRZN has outperformed the market in the last year with a return of +85.1%, while the SPY ETF gained +16.9%. In the last 3 month period, SRZN beat the market returning +14.5%, while SPY returned +3.7%. However, in the most recent 2 weeks SRZN has underperformed the stock market by returning -13.7%, while SPY returned -0.7%.
SRZN support price is $22.06 and resistance is $25.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SRZN shares will trade within this expected range on the day.
